Tesla shares fall 6% after report of robotaxi unveiling delay

Tesla shares fall 6% after report of robotaxi unveiling delay


Elon Musk, Chief Executive Officer of SpaceX and Tesla and owner of X speaks during the Milken Conference 2024 Global Conference Sessions at The Beverly Hilton in Beverly Hills, California, U.S., May 6, 2024. 

David Swanson | Reuters

Tesla shares fell about 6% on Thursday after Bloomberg reported that the electric vehicle maker is delaying the unveiling of its Robotaxi by two months.

After previously announcing that it would introduce its robotaxi on Aug. 8, Tesla has pushed the launch back to October to give teams working on the project more time to build prototypes, according to Bloomberg, which cited people familiar with the decision.

Tesla didn’t immediately respond to CNBC’s request for comment.

Tesla’s stock slump on Thursday followed an 11-day rally that was sparked by a better-than-expected deliveries report for the second quarter. That jump wiped out the stock’s loss for the year. However, the shares are now back in negative territory for 2024, a year that’s been marred by sweeping layoffs and a drop in sales due in part to an aging lineup of EVs and increased competition in China.

Tesla CEO Elon Musk has promised shareholders a robotaxi for years. In 2015, he said that Tesla’s cars would achieve “full autonomy” within three years. In 2016, Musk said Tesla would able to send one of its cars on a cross-country drive without requiring any human intervention by the end of the following year.

The empty promises continued into 2019, when Musk said on a call with institutional investors that Tesla would have 1 million robotaxi-ready vehicles on the road in 2020. However, the company has yet to deliver a robotaxi, autonomous vehicle or technology that can turn its cars into “level 3” automated vehicles. Meanwhile, companies like Alphabet’s Waymo and Cruise, owned by General Motors, have leaped ahead of Tesla.

Following a dreary first-quarter earnings report in April, Musk reiterated his vision of Tesla as a company dedicated to developing robotaxis that will make money for their owners and a driverless transportation network.

“If somebody doesn’t believe Tesla’s going to solve autonomy, I think they should not be an investor in the company,” Musk said on the earnings call. The company is scheduled to report second-quarter results later this month.

At Tesla, “unveil” dates do not predict a near-future date for a commercial release of a new product. For example, Tesla unveiled its fully electric heavy-duty truck, the Semi, in 2017 and didn’t begin deliveries until December 2022.

— CNBC’s Lora Kolodny contributed to this report.

WATCH: The bulls firmly have control of Tesla right now

The bulls firmly have control of Tesla right now, says Deepwater's Doug Clinton



Source

Tesla already had big problems. Then Musk went to battle with Trump
Technology

Tesla already had big problems. Then Musk went to battle with Trump

President Donald Trump holds a news conference with Elon Musk to mark the end of the Tesla CEO’s tenure as a special government employee overseeing the U.S. DOGE Service on Friday May 30, 2025 in the Oval Office of the White House in Washington. Tom Brenner | The Washington Post | Getty Images Tesla has […]

Read More
Winklevoss twins’ crypto firm Gemini confidentially files for IPO
Technology

Winklevoss twins’ crypto firm Gemini confidentially files for IPO

Cameron Winklevoss, co-founder and president of Gemini Trust Co., left, and Tyler Winklevoss, co-founder and chief executive officer of Gemini Trust Co., on stage during the Bitcoin 2025 conference in Las Vegas, Nevada, US, on Tuesday, May 27, 2025. Bridget Bennett | Bloomberg | Getty Images Gemini, the cryptocurrency exchange and custodian founded by Cameron […]

Read More
Omada shares open at  in Nasdaq debut after health-tech company’s IPO
Technology

Omada shares open at $23 in Nasdaq debut after health-tech company’s IPO

Omada Health shares popped more than 30% in their Nasdaq debut on Friday after the virtual chronic care company priced its stock at $19 per share in its IPO. The stock opened at $23 and quickly hit $25. The company said in a press release late Thursday that it sold 7.9 million shares in the […]

Read More